Keyphrases
Aged Mice
30%
Aging
14%
Aging Effect
15%
Anti-DNA Antibodies
45%
Autoantibodies
19%
Autoantibody Production
10%
Clinical Manifestations
12%
Complementarity-determining Region 3 (CDR3)
13%
Cytokine Production
27%
Cytokine Profile
10%
DRB1
10%
Elderly Patients
45%
Erythrocyte Sedimentation Rate
13%
First-degree Relatives
15%
Frail Elderly
16%
Geriatric Patients
15%
Idiotype
33%
Immune Response
15%
Immunization
21%
Increased Incidence
15%
Inflammatory Cytokines
10%
Interleukin-10
16%
Interleukin-1β
39%
Interleukin-2
13%
Interleukin-4 (IL-4)
16%
Israeli
10%
Israeli Jews
15%
Jewish Population
15%
Long-term Care
12%
Low-dose Methotrexate
11%
Mechanism of Action
13%
Methotrexate
70%
Methotrexate Treatment
32%
Monoclonal Antibody
16%
Nasogastric Tube
33%
Oral Administration
15%
Osteoarthritis
17%
Peptide-based
15%
Pharmacokinetics
16%
Proliferative Response
11%
Rheumatoid Arthritis
86%
Rheumatoid Arthritis Patients
16%
Systemic Lupus Erythematosus
100%
Systemic Lupus Erythematosus Patient
23%
T Cell Activation
15%
T Cells
17%
Th1 Cytokines
10%
Th2 Cytokines
11%
Tube Feeding
25%
Tumor Necrosis Factor-α
10%
Immunology and Microbiology
Acute Phase Response
7%
Antigen Specificity
11%
Antiidiotypic Antibody
8%
Antiphospholipid Antibody
7%
Aspartate Aminotransferase Blood Level
7%
Autoantibodies
30%
Blood Level
7%
CD4 CD8 Ratio
7%
Cell Activity
7%
Cell Function
7%
Complementarity Determining Region
10%
Computer Assisted Tomography
7%
Cytokine
49%
Cytokine Production
25%
DNA Antibody
11%
Erythrocyte Sedimentation Rate
11%
Experimental Systemic Lupus Erythematosus
62%
Haplotype
7%
HLA-B27
7%
Idiotype
28%
Immune Complex
8%
Immune Response
15%
Immunogenetics
7%
Immunosurveillance
7%
Inflammatory Arthritis
67%
Interleukin 10
13%
Interleukin 2
10%
Interleukin 4
11%
Interleukin-1
11%
Low Drug Dose
11%
Methotrexate
61%
Monoclonal Antibody
16%
Murine
8%
Peptides
23%
Peripheral Blood Lymphocyte
8%
Prostate
7%
Regulatory T Cell
8%
Rheumatic Disease
7%
Secretion (Process)
7%
Severe Combined Immunodeficiency
7%
Sjögren's Syndrome
15%
Systemic Lupus Erythematosus
71%
T Cell
20%
T Helper 1 Cell
7%
T Helper 2 Cell
7%
T Helper Cell
12%
Temporomandibular Joint
7%
Tumor Necrosis Factor
17%
Urinary Tract
7%
Vagina
7%